Terry-Ann Burrell, Chief Financial Officer at Beam Therapeutics Inc. (BEAM), sold 9,280 shares at $30.31 ($276K) on 2023-04-03, disclosed to the SEC on 2023-04-05.
Scheduled sale ($276k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.31 | 2,454 | $74K | 27.0% |
| 2 | $30.31 | 2,454 | $74K | 27.0% |
| 3 | $29.09 | 2,186 | $64K | 23.0% |
| 4 | $29.09 | 2,186 | $64K | 23.0% |
| Total | $29.74 avg | 9,280 | $276K | 100% |
| Filing → |
| BEAM | SELL | 2023-01-30 | $3.3M | — | Filing → |
| BEAM | SELL | 2023-01-25 | $1.8M | — | Filing → |
| BEAM | SELL | 2023-01-20 | $4.3M | — | Filing → |